260 related articles for article (PubMed ID: 8124800)
1. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
Circulation; 1994 Mar; 89(3):1138-43. PubMed ID: 8124800
[TBL] [Abstract][Full Text] [Related]
2. Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
Circulation; 1990 Nov; 82(5 Suppl):IV237-42. PubMed ID: 2225410
[TBL] [Abstract][Full Text] [Related]
3. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
[TBL] [Abstract][Full Text] [Related]
5. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.
Goldman S; Zadina K; Moritz T; Ovitt T; Sethi G; Copeland JG; Thottapurathu L; Krasnicka B; Ellis N; Anderson RJ; Henderson W;
J Am Coll Cardiol; 2004 Dec; 44(11):2149-56. PubMed ID: 15582312
[TBL] [Abstract][Full Text] [Related]
6. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
[TBL] [Abstract][Full Text] [Related]
7. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
[TBL] [Abstract][Full Text] [Related]
8. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040
[TBL] [Abstract][Full Text] [Related]
9. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
Circulation; 1991 Aug; 84(2):520-6. PubMed ID: 1860197
[TBL] [Abstract][Full Text] [Related]
10. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
Gao C; Ren C; Li D; Li L
Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
[TBL] [Abstract][Full Text] [Related]
13. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.
Gavaghan TP; Gebski V; Baron DW
Circulation; 1991 May; 83(5):1526-33. PubMed ID: 2022014
[TBL] [Abstract][Full Text] [Related]
14. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
[TBL] [Abstract][Full Text] [Related]
17. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
Zhu J; Zhu Y; Zhang M; Xue Q; Hu J; Liu H; Wang R; Wang X; Zhao Q
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1030-1039.e4. PubMed ID: 32359899
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
Sun JC; Teoh KH; Lamy A; Sheth T; Ellins ML; Jung H; Yusuf S; Anand S; Connolly S; Whitlock RP; Eikelboom JW
Am Heart J; 2010 Dec; 160(6):1178-84. PubMed ID: 21146675
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.
Kulik A; Voisine P; Mathieu P; Masters RG; Mesana TG; Le May MR; Ruel M
Ann Thorac Surg; 2011 Oct; 92(4):1284-90; discussion 1290-1. PubMed ID: 21958773
[TBL] [Abstract][Full Text] [Related]
20. Predictors of graft patency 3 years after coronary artery bypass graft surgery. Department of Veterans Affairs Cooperative Study Group No. 297.
Goldman S; Zadina K; Krasnicka B; Moritz T; Sethi G; Copeland J; Ovitt T; Henderson W
J Am Coll Cardiol; 1997 Jun; 29(7):1563-8. PubMed ID: 9180120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
